Mimedx Group Inc stock is traded at $3.36, with a volume of 188,839. It is up +2.29% in the last 24 hours and down -27.38% over the past month. MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Previous Close:
$3.28
Open:
$3.25
24h Volume:
188,839
Relative Volume:
0.09
Market Cap:
$489.58M
Revenue:
$389.42M
Net Income/Loss:
$30.70M
P/E Ratio:
16.42
EPS:
$0.2043
Net Cash Flow:
$67.23M
1W Performance:
-13.53%
1M Performance:
-27.38%
6M Performance:
-8.33%
1Y Performance:
-54.23%
1-Day Range:
$3.23$3.39
1-Week Range:
$3.05$3.88
52-Week Range:
$3.03$7.97
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group IncSector
HealthcareIndustry
BiotechnologyPhone
(770) 651-9100Address
1775 W OAK COMMONS COURT, NE, MARIETTA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS